Human dermal fibroblasts in psychiatry research

Neuroscience

Volumn 320, Issue , 2016, Pages 105-121

  Kalman S ^a   Garbett, K A ^b   Janka, Z ^a   Mirnics, K ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Bipolar disorder; Dermal fibroblasts; environment interaction; Gene; In vitro model; Major depression; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; NEUROLEPTIC AGENT; VALPROIC ACID;

ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; CIRCADIAN RHYTHM; DEPRESSION; DISEASE COURSE; FIBROBLAST; FRAGILE X SYNDROME; HUMAN; HUMAN DERMAL FIBROBLAST; LEUKOCYTE; LYMPHOCYTE; MENTAL DISEASE; MOLECULAR BIOLOGY; NERVOUS TISSUE; NONHUMAN; OLFACTORY EPITHELIUM; OXIDATION REDUCTION STATE; PATHOGENESIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; CELL CULTURE; MEDICAL RESEARCH; PROCEDURES; PSYCHIATRY; SKIN;

BIOMEDICAL RESEARCH; CELLS, CULTURED; FIBROBLASTS; HUMANS; MENTAL DISORDERS; MODELS, BIOLOGICAL; PSYCHIATRY; SKIN;

EID: 84958279978     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2016.01.067     Document Type: Review

References (208)

1. Akin D., Manier D.H., Sanders-Bush E., Shelton R.C. Decreased serotonin 5-HT2A receptor-stimulated phosphoinositide signaling in fibroblasts from melancholic depressed patients. Neuropsychopharmacology 2004, 29:2081-2087.
2. Akin D., Manier D.H., Sanders-Bush E., Shelton R.C. Signal transduction abnormalities in melancholic depression. Int J Neuropsychopharmacol 2005, 8(1):5-16.
3. Antequera F., Boyes J., Bird A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 1990, 62(3):503-514.
4. Auburger G., Klinkenberg M., Drost J., Marcus K., Morales-Gordo B., Kunz W.S., Brandt U., Broccoli V., Reichmann H., Gispert S., Jendrach M. Primary skin fibroblasts as a model of Parkinson's disease. Mol Neurobiol 2012, 46(1):20-27.
5. Bae S., An I.S., An S. Development of a high-throughput screening system for identification of novel reagents regulating DNA damage in human dermal fibroblasts. Acta Pharm 2015, 65(3):331-341.
6. Bajpai A., Verma A.K., Srivastava M., Srivastava R. Oxidative stress and major depression. J Clin Diagn Res 2014, 8(12):CC04-CC07.
7. Bamne M.N., Ponder C.A., Wood J.A., Mansour H., Frank E., Kupfer D.J., Young M.W., Nimgaonkar V.L. Application of an ex vivo cellular model of circadian variation for bipolar disorder research: a proof of concept study. Bipolar Disord 2013, 15(6):694-700.
8. Batalla A., Bargalló N., Gassó P., Molina O., Pareto D., Mas S., Roca J.M., Bernardo M., Lafuente A., Parellada E. Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naïve first-episode schizophrenia and healthy controls. Transl Psychiatry 2015, 5:e626.
9. Bayreuther K., Francz P.I., Gogol J., Hapke C., Maier M., Meinrath H.G. Differentiation of primary and secondary fibroblasts in cell culture systems. Mutat Res 1991, 256(2-6):233-242.
10. Bélanger M., Allaman I., Magistretti P.J. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab 2011, 14(6):724-738.
11. Belinsky G.S., Rich M.T., Sirois C.L., Short S.M., Pedrosa E., Lachman H.M., Antic S.D. Patch-clamp recordings and calcium imaging followed by single-cell PCR reveal the developmental profile of 13 genes in iPSC-derived human neurons. Stem Cell Res 2014, 12(1):101-118.
12. Benedetti F., Dallaspezia S., Colombo C., Pirovano A., Marino E., Smeraldi E. A length polymorphism in the circadian clock gene Per3 influences age at onset of bipolar disorder. Neurosci Lett 2008, 445(2):184-187.
13. Benito E., Barco A. The neuronal activity-driven transcriptome. Mol Neurobiol 2015, 51(3):1071-1088.
14. Berretta S., Pantazopoulos H., Markota M., Brown C., Batzianouli E.T. Losing the sugar coating: Potential impact of perineuronal net abnormalities on interneurons in schizophrenia. Schizophr Res 2015, 167(1-3):18-27.
15. Berrettini W.H., Bardakjian J., Cappellari C.B., Barnett A.L., Albright A., Nurnberger J.I., Gershon E.S. Skin fibroblast beta-adrenergic receptor function in manic-depressive illness. Biol Psychiatry 1987, 22(12):1439-1443.
16. Biran R., Noble M.D., Tresco P.A. Characterization of cortical astrocytes on materials of differing surface chemistry. J Biomed Mater Res 1999, 46(2):150-159.
17. Bongiovanni R., Leonard S., Jaskiw G.E. A simplified method to quantify dysregulated tyrosine transport in schizophrenia. Schizophr Res 2013, 150(2-3):386-391.
18. Borgmann-Winter K., Willard S.L., Sinclair D., Mirza N., Turetsky B., Berretta S., Hahn C.G. Translational potential of olfactory mucosa for the study of neuropsychiatric illness. Transl Psychiatry 2015, 5:e527.
19. Breakefield X.O., Giller E.L., Nurnberger J.I., Castiglione C.M., Buchsbaum M.S., Gershon E.S. Monoamine oxidase type A in fibroblasts from patients with bipolar depressive illness. Psychiatry Res 1980, 2(3):307-314.
20. Brennand K.J., Simone A., Tran N., Gage F.H. Modeling psychiatric disorders at the cellular and network levels. Mol Psychiatry 2012, 17(12):1239-1253.
21. Brennand K.J., Landek-Salgado M.A., Sawa A. Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells. Biol Psychiatry 2014, 75(12):936-944.
22. Breslow R.E., DeMuth G.W., Weiss C. Lithium incorporation in the fibroblasts of manic-depressives. Biol Psychiatry 1985, 20(1):58-65.
23. Brown S.A., Fleury-Olela F., Nagoshi E., Hauser C., Juge C., Meier C.A., Chicheportiche R., Dayer J.M., Albrecht U., Schibler U. The period length of fibroblast circadian gene expression varies widely among human individuals. PLoS Biol 2005, 3(10):e338.
24. Brown J.A., Sherrod S.D., Goodwin C.R., Brewer B., Yang L., Garbett K.A., Li D., McLean J.A., Wikswo J.P., Mirnics K. Metabolic consequences of interleukin-6 challenge in developing neurons and astroglia. J Neuroinflamm 2014, 11:183.
25. Brown J.A., Ramikie T.S., Schmidt M.J., Báldi R., Garbett K., Everheart M.G., Warren L.E., Gellért L., Horváth S., Patel S., Mirnics K. Inhibition of parvalbumin-expressing interneurons results in complex behavioral changes. Mol Psychiatry 2015.
26. Bruinvels J., Pepplinkhuizen L., Fekkes D. Derangement of one-carbon metabolism in episodic schizoaffective psychoses. Pharm Psychiatry 1988, 21(1):28-32.
27. Cataldo A.M., McPhie D.L., Lange N.T., Punzell S., Elmiligy S., Ye N.Z., Froimowitz M.P., Hassinger L.C., Menesale E.B., Sargent L.W., Logan D.J., Carpenter A.E., Cohen B.M. Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathol 2010, 177(2):575-585.
28. Cattane N., Minelli A., Milanesi E., Maj C., Bignotti S., Bortolomasi M., Bocchio Chiavetto L., Gennarelli M. Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood. PLoS One 2015, 10(2):e0116686.
29. Catts V.S., Catts S.V., McGrath J.J., Féron F., McLean D., Coulson E.J., Lutze-Mann L.H. Apoptosis and schizophrenia: a pilot study based on dermal fibroblast cell lines. Schizophr Res 2006, 84(1):20-28.
30. Chanda S., Ang C.E., Davila J., Pak C., Mall M., Lee Q.Y., Ahlenius H., Jung S.W., Südhof T.C., Wernig M. Generation of induced neuronal cells by the single reprogramming factor ASCL1. Stem Cell Rep 2014, 3(2):282-296.
31. Chen Y.W., Lin P.Y., Tu K.Y., Cheng Y.S., Wu C.K., Tseng P.T. Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review. Neuropsychiatry Dis Treat 2015, 11:925-933.
32. Coffey E.E., Beckel J.M., Laties A.M., Mitchell C.H. Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer's disease-linked presenilin 1 A246E mutation can be reversed with cAMP. Neuroscience 2014, 263:111-124.
33. Cohen M.R., Sailer V., McAmis B., Jenkins P. Superoxide dismutase activity in fibroblasts from patients with schizophrenia. Biol Psychiatry 1986, 21(3):322-324.
34. Cohen M.R., Gutman R., McAmis W. Cultured skin fibroblasts in schizophrenia: acute growth and susceptibility to damage. Psychiatry Res 1987, 21(1):43-47.
35. Cohen M.R., McAmis W., Gutman R. Sensitivity to N-methyl-N'-nitro-N-nitrosoguanidine in fibroblasts from patients with schizophrenia. Biol Psychiatry 1989, 25(2):239-242.
36. Connolly G.P. Fibroblast models of neurological disorders: fluorescence measurement studies. Trends Pharmacol Sci 1998, 19(5):171-177.
37. Cordero M.D., Moreno-Fernández A.M., Gomez-Skarmeta J.L., de Miguel M., Garrido-Maraver J., Oropesa-Avila M., Rodríguez-Hernández A., Navas P., Sánchez-Alcázar J.A. Coenzyme Q10 and alpha-tocopherol protect against amitriptyline toxicity. Toxicol Appl Pharmacol 2009, 235(3):329-337.
38. Corrales N.L., Mrasek K., Voigt M., Liehr T., Kosyakova N. Copy number variations (CNVs) in human pluripotent cell-derived neuroprogenitors. Gene 2012, 506(2):377-379.
39. Dage J.L., Colvin E.M., Fouillet A., Langron E., Roell W.C., Li J., Mathur S.X., Mogg A.J., Schmitt M.G., Felder C.C., Merchant K.M., Isaac J., Broad L.M., Sher E., Ursu D. Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons. Psychopharmacology 2014, 231(6):1105-1124.
40. De Filippi L., Fournier M., Cameroni E., Linder P., De Virgilio C., Foti M., Deloche O. Membrane stress is coupled to a rapid translational control of gene expression in chlorpromazine-treated cells. Curr Genet 2007, 52(3-4):171-185.
41. Dietschy J.M., Turley S.D. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 2004, 45(8):1375-1397.
42. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., Croft G.F., Saphier G., Leibel R., Goland R., Wichterle H., Henderson C.E., Eggan K. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321(5893):1218-1221.
43. Do K.Q., Trabesinger A.H., Kirsten-Krüger M., Lauer C.J., Dydak U., Hell D., Holsboer F., Boesiger P., Cuénod M. Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 2000, 12(10):3721-3728.
44. Druzd D., de Juan A., Scheiermann C. Circadian rhythms in leukocyte trafficking. Semin Immunopathol. 2014, 36(2):149-162.
45. Dwivedi Y., Pandey G.N. Adenylyl cyclase-cyclicAMP signaling in mood disorders: role of the crucial phosphorylating enzyme protein kinase A. Neuropsychiatry Dis Treat 2008, 4(1):161-176.
46. Dwivedi Y., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. [(3)H]cAMP binding sites and protein kinase a activity in the prefrontal cortex of suicide victims. Am J Psychiatry 2002, 159(1):66-73.
47. Ebert A.D., Yu J., Rose F.F., Mattis V.B., Lorson C.L., Thomson J.A., Svendsen C.N. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457(7227):277-280.
48. Eroglu C., Barres B.A. Regulation of synaptic connectivity by glia. Nature 2010, 468(7321):223-231.
49. Evangelisti E., Zampagni M., Cascella R., Becatti M., Fiorillo C., Caselli A., Bagnoli S., Nacmias B., Cecchi C. Plasma membrane injury depends on bilayer lipid composition in Alzheimer's disease. J Alzheimers Dis 2014, 41(1):289-300.
50. Faissner A., Pyka M., Geissler M., Sobik T., Frischknecht R., Gundelfinger E.D., Seidenbecher C. Contributions of astrocytes to synapse formation and maturation - Potential functions of the perisynaptic extracellular matrix. Brain Res Rev 2010, 63(1-2):26-38.
51. Fathi A., Hatami M., Hajihosseini V., Fattahi F., Kiani S., Baharvand H., Salekdeh G.H. Comprehensive gene expression analysis of human embryonic stem cells during differentiation into neural cells. PLoS One 2011, 6(7):e22856.
52. Fekkes D., Bruinvels J. Serine and folate metabolism in fibroblasts from episodic psychotic patients with psychedelic symptoms. Biol Psychiatry 1986, 21(10):951-959.
53. Fernell E., Karagiannakis A., Edman G., Bjerkenstedt L., Wiesel F.A., Venizelos N. Aberrant amino acid transport in fibroblasts from children with autism. Neurosci Lett 2007, 418(1):82-86.
54. Féron F., Perry C., Girard S.D., Mackay-Sim A. Isolation of adult stem cells from the human olfactory mucosa. Methods Mol Biol 2013, 1059:107-114.
55. Flyckt L., Venizelos N., Edman G., Bjerkenstedt L., Hagenfeldt L., Wiesel F.A. Aberrant tyrosine transport across the cell membrane in patients with schizophrenia. Arch Gen Psychiatry 2001, 58(10):953-958.
56. Forrest M.P., Hill M.J., Quantock A.J., Martin-Rendon E., Blake D.J. The emerging roles of TCF4 in disease and development. Trends Mol Med 2014, 20(6):322-331.
57. Fournier M., Ferrari C., Baumann P.S., Polari A., Monin A., Bellier-Teichmann T., Wulff J., Pappan K.L., Cuenod M., Conus P., Do K.Q. Impaired metabolic reactivity to oxidative stress in early psychosis patients. Schizophr Bull 2014, 40(5):973-983.
58. Fridman A.L., Tainsky M.A. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene 2008, 27(46):5975-5987.
59. Fullár A., Dudás J., Oláh L., Hollósi P., Papp Z., Sobel G., Karászi K., Paku S., Baghy K., Kovalszky I. Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression. BMC Cancer 2015, 15:256.
60. Garbett K.A., Vereczkei A., Kálmán S., Wang L., Korade Ž., Shelton R.C., Mirnics K. Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors. Transl Psychiatry 2015, 5:e523.
61. Garbett K.A., Vereczkei A., Kálmán S., Brown J.A., Taylor W.D., Faludi G., Korade Ž., Shelton R.C., Mirnics K. Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression. Biol Psychiatry 2015, 77(3):256-265.
62. Garriock H.A., Kraft J.B., Shyn S.I., Peters E.J., Yokoyama J.S., Jenkins G.D., Reinalda M.S., Slager S.L., McGrath P.J., Hamilton S.P. A genomewide association study of citalopram response in major depressive disorder. Biol Psychiatry 2010, 67(2):133-138.
63. Gaspar L., van de Werken M., Johansson A.S., Moriggi E., Owe-Larsson B., Kocks J.W., Lundkvist G.B., Gordijn M.C., Brown S.A. Human cellular differences in cAMP-CREB signaling correlate with light-dependent melatonin suppression and bipolar disorder. Eur J Neurosci 2014, 40(1):2206-2215.
64. Gassó P., Mas S., Molina O., Lafuente A., Bernardo M., Parellada E. Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patients. J Psychiatry Res 2014, 48(1):94-101.
65. Gibson S.A., Korade Z., Shelton R.C. Oxidative stress and glutathione response in tissue cultures from persons with major depression. J Psychiatry Res 2012, 46(10):1326-1332.
66. Giller E.L., Young J.G., Breakefield X.O., Carbonari C., Braverman M., Cohen D.J. Monoamine oxidase and catechol-O-methyltransferase activities in cultured fibroblasts and blood cells from children with autism and the Gilles de la Tourette syndrome. Psychiatry Res 1980, 2(2):187-197.
67. Giller E., Nocks J., Hall H., Stewart C., Schnitt J., Sherman B. Platelet and fibroblast monoamine oxidase in alcoholism. Psychiatry Res 1984, 12(4):339-347.
68. Gladkevich A., Kauffman H.F., Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28(3):559-576.
69. Glaros T., Larsen M., Li L. Macrophages and fibroblasts during inflammation, tissue damage and organ injury. Front Biosci (Landmark Ed) 2009, 14:3988-3993.
70. Gomez G., Rawson N.E., Hahn C.G., Michaels R., Restrepo D. Characteristics of odorant elicited calcium changes in cultured human olfactory neurons. J Neurosci Res 2008, 62(5):737-749.
71. Gong Q., He Y. Depression, neuroimaging and connectomics: a selective overview. Biol Psychiatry 2015, 77(3):223-235.
72. Greiner J.F., Hauser S., Widera D., Müller J., Qunneis F., Zander C., Martin I., Mallah J., Schuetzmann D., Prante C., Schwarze H., Prohaska W., Beyer A., Rott K., Hütten A., Gölzhäuser A., Sudhoff H., Kaltschmidt C., Kaltschmidt B. Efficient animal-serum free 3D cultivation method for adult human neural crest-derived stem cell therapeutics. Eur Cell Mater 2011, 22:403-419.
73. Groshong R., Baldessarini R.J., Gibson D.A., Lipinski J.F., Axelrod D., Pope A. Activities of types A and B MAO and catechol-o-methyltransferase in blood cells and skin fibroblasts of normal and chronic schizophrenic subjects. Arch Gen Psychiatry 1978, 35(10):1198-1205.
74. Gundelfinger E.D., Frischknecht R., Choquet D., Heine M. Converting juvenile into adult plasticity: a role for the brain's extracellular matrix. Eur J Neurosci 2010, 31(12):2156-2165.
75. Gurung R., Prata D.P. What is the impact of genome-wide supported risk variants for schizophrenia and bipolar disorder on brain structure and function? A systematic review. Psychol Med 2015, 10:1-20.
76. Gysin R., Kraftsik R., Sandell J., Bovet P., Chappuis C., Conus P., Deppen P., Preisig M., Ruiz V., Steullet P., Tosic M., Werge T., Cuénod M., Do K.Q. Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc Natl Acad Sci U S A 2007, 104(42):16621-16626.
77. Gysin R., Riederer I.M., Cuénod M., Do K.Q., Riederer B.M. Skin fibroblast model to study an impaired glutathione synthesis: consequences of a genetic polymorphism on the proteome. Brain Res Bull 2009, 79(1):46-52.
78. Gysin R., Kraftsik R., Boulat O., Bovet P., Conus P., Comte-Krieger E., Polari A., Steullet P., Preisig M., Teichmann T., Cuénod M., Do K.Q. Genetic dysregulation of glutathione synthesis predicts alteration of plasma thiol redox status in schizophrenia. Antioxid Redox Signal 2011, 15(7):2003-2010.
79. Hagenfeldt L., Venizelos N., Bjerkenstedt L., Wiesel F.A. Decreased tyrosine transport in fibroblasts from schizophrenic patients. Life Sci 1987, 41(25):2749-2757.
80. Hänzelmann S., Beier F., Gusmao E.G., Koch C.M., Hummel S., Charapitsa I., Joussen S., Benes V., Brümmendorf T.H., Reid G., Costa I.G., Wagner W. Replicative senescence is associated with nuclear reorganization and with DNA methylation at specific transcription factor binding sites. Clin Epigenet 2015, 7(1):19.
81. Hayashi-Takagi A., Vawter M.P., Iwamoto K. Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research. Biol Psychiatry 2014, 75(12):920-928.
82. Hitzemann R., Kao L., Hirschowitz J., Garver D., Gruenstein E. Lithium transport in human fibroblasts: relationship to RBC lithium transport and psychiatric diagnoses. Psychiatry Res 1988, 24(3):337-344.
83. Horváth S., Mirnics K. Schizophrenia as a disorder of molecular pathways. Biol Psychiatry 2015, 77(1):22-28.
84. Horváth S., Janka Z., Mirnics K. Analyzing schizophrenia by DNA microarrays. Biol Psychiatry 2011, 69(2):157-162.
85. Hu B.Y., Weick J.P., Yu J., Ma L.X., Zhang X.Q., Thomson J.A., Zhang S.C. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A 2010, 107(9):4335-4340.
86. Huang H.M., Fowler C., Xu H., Zhang H., Gibson G.E. Mitochondrial function in fibroblasts with aging in culture and/or Alzheimer's disease. Neurobiol Aging 2005, 26(6):839-848.
87. Huard J.M., Youngentob S.L., Goldstein B.J., Luskin M.B., Schwob J.E. Adult olfactory epithelium contains multipotent progenitors that give rise to neurons and non-neural cells. J Comp Neurol 1998, 400(4):469-486.
88. Hung Y.Y., Kang H.Y., Huang K.W., Huang T.L. Association between toll-like receptors expression and major depressive disorder. Psychiatry Res 2014, 220(1-2):283-286.
89. Iafrati J., Orejarena M.J., Lassalle O., Bouamrane L., Gonzalez-Campo C., Chavis P. Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARsand the mTOR pathway. Mol Psychiatry 2014, 19(4):417-426.
90. Iga J., Ueno S., Ohmori T. Molecular assessment of depression from mRNAs in the peripheral leukocytes. Ann Med 2008, 40(5):336-342.
91. Israel M.A., Yuan S.H., Bardy C., Reyna S.M., Mu Y., Herrera C., Hefferan M.P., Van Gorp S., Nazor K.L., Boscolo F.S., Carson C.T., Laurent L.C., Marsala M., Gage F.H., Remes A.M., Koo E.H., Goldstein L.S. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 2012, 482(7384):216-220.
92. Jagannath A., Peirson S.N., Foster R.G. Sleep and circadian rhythm disruption in neuropsychiatric illness. Curr Opin Neurobiol 2013, 23(5):888-894.
93. Johansson A.S., Brask J., Owe-Larsson B., Hetta J., Lundkvist G.B. Valproic acid phase shifts the rhythmic expression of Period2::Luciferase. J Biol Rhythms 2011, 26(6):541-551.
94. Johansson J., Landgren M., Fernell E., Vumma R., Åhlin A., Bjerkenstedt L., Venizelos N. Altered tryptophan and alanine transport in fibroblasts from boys with attention-deficit/hyperactivity disorder (ADHD): an in vitro study. Behav Brain Funct 2011, 7:40.
95. Johansson A.S., Owe-Larsson B., Asp L., Kocki T., Adler M., Hetta J., Gardner R., Lundkvist G.B., Urbanska E.M., Karlsson H. Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine. J Psychiatry Res 2013, 47(11):1815-1823.
96. Johansson J., Landgren M., Fernell E., Lewander T., Venizelos N. Decreased binding capacity (Bmax) of muscarinic acetylcholine receptors in fibroblasts from boys with attention-deficit/hyperactivity disorder (ADHD). Atten Def Hyperact Disord 2013, 5(3):267-271.
97. Kaiser T., Feng G. Modeling psychiatric disorders for developing effective treatments. Nat Med 2015, 21(9):979-988.
98. Kálmán S., Garbett K.A., Vereczkei A., Shelton R.C., Korade Z., Mirnics K. Metabolic stress-induced microRNA and mRNA expression profiles of human fibroblasts. Exp Cell Res 2014, 320(2):343-353.
99. Khandaker G.M., Dantzer R. Is there a role for immune-to-brain communication in schizophrenia?. Psychopharmacology 2015.
100. Kim D.S., Ross P.J., Zaslavsky K., Ellis J. Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD. Front Cell Neurosci 2014, 8:109.
101. Kirkpatrick B., Messias E., Harvey P.D., Fernandez-Egea E., Bowie C.R. Is schizophrenia a syndrome of accelerated aging?. Schizophr Bull 2008, 34(6):1024-1032.
102. Koch C.M., Suschek C.V., Lin Q., Bork S., Goergens M., Joussen S., Pallua N., Ho A.D., Zenke M., Wagner W. Specific age-associated DNA methylation changes in human dermal fibroblasts. PLoS One 2011, 6(2):e16679.
103. Krieger K., Klimke A., Henning U. Active [3H]-dopamine uptake displayed by native lymphocyte suspensions is mainly due to contaminating platelets. Pharmacopsychiatry 1998, 31(5):193-198.
104. Kubben N., Brimacombe K.R., Donegan M., Li Z., Misteli T. A high-content imaging-based screening pipeline for the systematic identification of anti-progeroid compounds. Methods 2015, pii: S1046-2023(15)30070-0.
105. Kumari D., Bhattacharya A., Nadel J., Moulton K., Zeak N.M., Glicksman A., Dobkin C., Brick D.J., Schwartz P.H., Smith C.B., Klann E., Usdin K. Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs. Hum Mutat 2014, 35(12):1485-1494.
106. Kurian S.M., Le-Niculescu H., Patel S.D., Bertram D., Davis J., Dike C., Yehyawi N., Lysaker P., Dustin J., Caligiuri M., Lohr J., Lahiri D.K., Nurnberger J.I., Faraone S.V., Geyer M.A., Tsuang M.T., Schork N.J., Salomon D.R., Niculescu A.B. Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry 2011, 16(1):37-58.
107. Kyosseva S.V. Differential expression of mitogen-activated protein kinases and immediate early genes fos and jun in thalamus in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28(6):997-1006.
108. Lauth M., Rohnalter V., Bergström A., Kooshesh M., Svenningsson P., Toftgård R. Antipsychotic drugs regulate hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels. Mol Pharmacol 2010, 78(3):486-496.
109. Lee K.M., MacLean A.G. New advances on glial activation in health and disease. World J Virol 2015, 4(2):42-55.
110. Leeb C., Eresheim C., Nimpf J. Clusterin is a ligand for apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and signals via the Reelin-signaling pathway. J Biol Chem 2014, 289(7):4161-4172.
111. Lemons J.M., Feng X.J., Bennett B.D., Legesse-Miller A., Johnson E.L., Raitman I., Pollina E.A., Rabitz H.A., Rabinowitz J.D., Coller H.A. Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol 2010, 8(10):e1000514.
112. Leonard B.E. Inflammation, depression and dementia: are they connected?. Neurochem Res 2007, 32(10):1749-1756.
113. Liu J.P. Molecular mechanisms of ageing and related diseases. Clin Exp Pharmacol Physiol 2014, 41(7):445-458.
114. Liu Y., Liu H., Sauvey C., Yao L., Zarnowska E.D., Zhang S.C. Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells. Nat Protoc 2013, 8(9):1670-1679.
115. Logue M.W., Baldwin C., Guffanti G., Melista E., Wolf E.J., Reardon A.F., Uddin M., Wildman D., Galea S., Koenen K.C., Miller M.W. A genome-wide association study of post-traumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus. Mol Psychiatry 2013, 18(8):937-942.
116. Lonze B.E., Ginty D.D. Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002, 35(4):605-623.
117. Lu P., Takai K., Weaver V.M., Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 2011, 3(12). pii: a005058.
118. Lubbers B.R., Smit A.B., Spijker S., van den Oever M.C. Neural ECM in addiction, schizophrenia, and mood disorder. Prog Brain Res 2014, 214:263-284.
119. Lundgaard I., Osório M.J., Kress B.T., Sanggaard S., Nedergaard M. White matter astrocytes in health and disease. Neuroscience 2014, 276:161-173.
120. Mahadik S.P., Mukherjee S., Laev H., Reddy R., Schnur D.B. Abnormal growth of skin fibroblasts from schizophrenic patients. Psychiatry Res 1991, 37(3):309-320.
121. Mahadik S.P., Mukherjee S., Correnti E.E., Kelkar H.S., Wakade C.G., Costa R.M., Scheffer R. Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis. Schizophr Res 1994, 13(3):239-247.
122. Mahadik S.P., Mukherjee S., Wakade C.G., Laev H., Reddy R.R., Schnur D.B. Decreased adhesiveness and altered cellular distribution of fibronectin in fibroblasts from schizophrenic patients. Psychiatry Res 1994, 53(1):87-97.
123. Mahadik S.P., Mukherjee S., Horrobin D.F., Jenkins K., Correnti E.E., Scheffer R.E. Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects. Psychiatry Res 1996, 63(2-3):133-142.
124. Mahadik S.P., Shendarkar N.S., Scheffer R.E., Mukherjee S., Correnti E.E. Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls. Prostaglandins Leukot Essent Fatty Acids 1996, 55(1-2):65-70.
125. Maier A.B., le Cessie S., de Koning-Treurniet C., Blom J., Westendorp R.G., van Heemst D. Persistence of high-replicative capacity in cultured fibroblasts from nonagenarians. Aging Cell 2007, 6(1):27-33.
126. Manier D.H., Shelton R.C., Ellis T.C., Peterson C.S., Eiring A., Sulser F. Human fibroblasts as a relevant model to study signal transduction in affective disorders. J Affect Disord 2000, 61(1-2):51-58.
127. Manier D.H., Shelton R.C., Sulser F. Cross-talk between PKA and PKC in human fibroblasts: what are the pharmacotherapeutic implications?. J Affect Disord 2001, 65(3):275-279.
128. Martins-Taylor K., Xu R.H. Concise review: Genomic stability of human induced pluripotent stem cells. Stem Cells 2012, 30(1):22-27.
129. Matigian N.A., McCurdy R.D., Féron F., Perry C., Smith H., Filippich C., McLean D., McGrath J., Mackay-Sim A., Mowry B., Hayward N.K. Fibroblast and lymphoblast gene expression profiles in schizophrenia: are non-neural cells informative?. PLoS One 2008, 3(6):e2412.
130. McCarthy M.J., Wei H., Marnoy Z., Darvish R.M., McPhie D.L., Cohen B.M., Welsh D.K. Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients. Transl Psychiatry 2013, 3:e318.
131. McCarthy M.J., Fernandes M., Kranzler H.R., Covault J.M., Welsh D.K. Circadian clock period inversely correlates with illness severity in cells from patients with alcohol use disorders. Alcohol Clin Exp Res 2013, 37(8):1304-1310.
132. McCarthy M.J., LeRoux M., Wei H., Beesley S., Kelsoe J.R., Welsh D.K. Calcium channel genes associated with bipolar disorder modulate lithium's amplification of circadian rhythms. Neuropharmacology 2015, 101:439-448.
133. McGlashan T.H. Eugen Bleuler: centennial anniversary of his 1911 publication of Dementia Praecox or the group of schizophrenias. Schizophr Bull 2011, 37(6):1101-1103.
134. Meister A. Glutathione biosynthesis and its inhibition. Methods Enzymol 1995, 252:26-30.
135. Mertens J., Paquola A.C., Ku M., Hatch E., Böhnke L., Ladjevardi S., McGrath S., Campbell B., Lee H., Herdy J.R., Gonçalves J.T., Toda T., Kim Y., Winkler J., Yao J., Hetzer M.W., Gage F.H. Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects. Cell Stem Cell 2015, S1934-5909(15). pii:00408-7.
136. Mirnics K., Levitt P., Lewis D.A. Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry 2006, 60(2):163-176.
137. Moore N.H., Costa L.G., Shaffer S.A., Goodlett D.R., Guizzetti M. Shotgun proteomics implicates extracellular matrix proteins and protease systems in neuronal development induced by astrocyte cholinergic stimulation. J Neurochem 2009, 108(4):891-908.
138. Moreira P.I., Harris P.L., Zhu X., Santos M.S., Oliveira C.R., Smith M.A., Perry G. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. J Alzheimers Dis 2007, 12(2):195-206.
139. Mössner R., Daniel S., Albert D., Heils A., Okladnova O., Schmitt A., Lesch K.P. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int 2000, 36(3):197-202.
140. Mukherjee A.B., Svoronos S., Ghazanfari A., Martin P.R., Fisher A., Roecklein B., Rodbard D., Staton R., Behar D., Berg C.J. Transketolase abnormality incultured fibroblasts from familial chronic alcoholic men and their maleoffspring. J Clin Invest 1987, 79(4):1039-1043.
141. Müller N., Myint A.M., Schwarz M.J. Inflammation in schizophrenia. Adv Protein Chem Struct Biol 2012, 88:49-68.
142. Munzer A., Sack U., Mergl R., Schönherr J., Petersein C., Bartsch S., Kirkby K.C., Bauer K., Himmerich H. Impact of antidepressants on cytokine production of depressed patients in vitro. Toxins (Basel) 2013, 5(11):2227-2240.
143. Musliner K.L., Seifuddin F., Judy J.A., Pirooznia M., Goes F.S., Zandi P.P. Polygenic risk, stressful life events and depressive symptoms in older adults: a polygenic score analysis. Psychol Med 2015, 45(8):1709-1720.
144. Naba A., Clauser K.R., Ding H., Whittaker C.A., Carr S.A., Hynes R.O. The extracellular matrix: tools and insights for the "omics" era. Matrix Biol 2015, pii: S0945-053X(15)00121-3.
145. Naderi J., Lopez C., Pandey S. Chronically increased oxidative stress in fibroblasts from Alzheimer's disease patients causes early senescence and renders resistance to apoptosis by oxidative stress. Mech Ageing Dev 2006, 127(1):25-35.
146. Nadi N.S., Nurnberger J.I., Gershon E.S. Muscarinic cholinergic receptors on skin fibroblasts in familial affective disorder. N Engl J Med 1984, 311(4):225-230.
147. Nagoshi E., Saini C., Bauer C., Laroche T., Naef F., Schibler U. Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell 2004, 119(5):693-705.
148. Naydenov A.V., MacDonald M.L., Ongur D., Konradi C. Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Arch Gen Psychiatry 2007, 64(5):555-564.
149. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat Neurosci 2010, 13(10):1161-1169.
150. Nestor C.E., Ottaviano R., Reinhardt D., Cruickshanks H.A., Mjoseng H.K., McPherson R.C., Lentini A., Thomson J.P., Dunican D.S., Pennings S., Anderton S.M., Benson M., Meehan R.R. Rapid reprogramming of epigenetic and transcriptional profiles in mammalian culture systems. Genome Biol 2015, 16(1):11.
151. Olsson E., Wiesel F.A., Bjerkenstedt L., Venizelos N. Tyrosine transport in fibroblasts from healthy volunteers and patients with schizophrenia. Neurosci Lett 2006, 393(2-3):211-215.
152. Ovadia G., Shifman S. The genetic variation of RELN expression in schizophrenia and bipolar disorder. PLoS One 2011, 6(5):e19955.
153. Pagani L., Semenova E.A., Moriggi E., Revell V.L., Hack L.M., Lockley S.W., Arendt J., Skene D.J., Meier F., Izakovic J., Wirz-Justice A., Cajochen C., Sergeeva O.J., Cheresiz S.V., Danilenko K.V., Eckert A., Brown S.A. The physiological period length of the human circadian clock in vivo is directly proportional to period in human fibroblasts. PLoS One 2010, 5(10):e13376.
154. Palazzo E., Marconi A., Truzzi F., Dallaglio K., Petrachi T., Humbert P., Schnebert S., Perrier E., Dumas M., Pincelli C. Role of neurotrophins on dermal fibroblast survival and differentiation. J Cell Physiol 2012, 227(3):1017-1025.
155. Palotás A., Kálmán J., Palotás M., Juhász A., Janka Z., Penke B. Fibroblasts and lymphocytes from Alzheimer patients are resistant to beta-amyloid-induced increase in the intracellular calcium concentration. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26(5):971-974.
156. Pang Z.P., Yang N., Vierbuchen T., Ostermeier A., Fuentes D.R., Yang T.Q., Citri A., Sebastiano V., Marro S., Südhof T.C., Wernig M. Induction of human neuronal cells by defined transcription factors. Nature 2011, 476(7359):220-223.
157. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M.W., Cowan C., Hochedlinger K., Daley G.Q. Disease-specific induced pluripotent stem cells. Cell 2008, 134(5):877-886.
158. Penninx B.W., Milaneschi Y., Lamers F., Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med 2013, 11:129.
159. Persson M.L., Johansson J., Vumma R., Raita J., Bjerkenstedt L., Wiesel F.A., Venizelos N. Aberrant amino acid transport in fibroblasts from patients with bipolar disorder. Neurosci Lett 2009, 457(1):49-52.
160. Peterson C., Goldman J.E. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc Natl Acad Sci U S A 1986, 83(8):2758-2762.
161. Przybyla L.M., Theunissen T.W., Jaenisch R., Voldman J. Matrix remodeling maintains embryonic stem cell self-renewal by activating Stat3. Stem Cells 2013, 31(6):1097-1106.
162. Ramchand C.N., Das I., Gliddon A., Hirsch S.R. Role of polyamines in the membrane pathology of schizophrenia. A study using fibroblasts from schizophrenic patients and normal controls. Schizophr Res 1994, 13(3):249-253.
163. Ramchand C.N., Gliddon A.E., Clark A.E., Hemmings G.P. Glucose oxidation and monoamine oxidase activity from the fibroblasts of schizophrenic patients and controls. Life Sci 1995, 56(19):1639-1646.
164. Ramchand C.N., Peet M., Clark A.E., Gliddon A.E., Hemmings G.P. Decreased tyrosine transport in fibroblasts from schizophrenics: implications for membrane pathology. Prostaglandins Leukot Essent Fatty Acids 1996, 55(1-2):59-64.
165. Ranjekar P.K., Hinge A., Hegde M.V., Ghate M., Kale A., Sitasawad S., Wagh U.V., Debsikdar V.B., Mahadik S.P. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 2003, 121(2):109-122.
166. Reyazuddin M., Azmi S.A., Islam N., Rizvi A. Oxidative stress and level of antioxidant enzymes in drug-naive schizophrenics. Ind J Psychiatry 2014, 56(4):344-349.
167. Rieske P., Krynska B., Azizi S.A. Human fibroblast-derived cell lines have characteristics of embryonic stem cells and cells of neuro-ectodermal origin. Differentiation 2005, 73:474-483.
168. Rohani L., Johnson A.A., Arnold A., Stolzing A. The aging signature: a hallmark of induced pluripotent stem cells?. Aging Cell 2014, 13(1):2-7.
169. Saini C., Brown S.A., Dibner C. Human peripheral clocks: applications for studying circadian phenotypes in physiology and pathophysiology. Front Neurol 2015, 6:95.
170. Sanacora G., Banasr M. From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry 2013, 73(12):1172-1179.
171. Santarelli S., Lesuis S.L., Wang X.D., Wagner K.V., Hartmann J., Labermaier C., Scharf S.H., Müller M.B., Holsboer F., Schmidt M.V. Evidence supporting the match/mismatch hypothesis of psychiatric disorders. Eur Neuropsychopharmacol 2014, 24(6):907-918.
172. Sarnyai Z., Alsaif M., Bahn S., Ernst A., Guest P.C., Hradetzky E., Kluge W., Stelzhammer V., Wesseling H. Behavioral and molecular biomarkers in translational animal models for neuropsychiatric disorders. Int Rev Neurobiol 2011, 101:203-238.
173. Schmidt M.J., Mirnics K. Modeling interneuron dysfunction in schizophrenia. Dev Neurosci 2012, 34(2-3):152-158.
174. Schmidt M.J., Horvath S., Ebert P., Norris J.L., Seeley E.H., Brown J., Gellert L., Everheart M., Garbett K.A., Grice T.W., Caprioli R.M., Mirnics K. Modulation of behavioral networks by selective interneuronal inactivation. Mol Psychiatry 2014, 19(5):580-587.
175. Schmitt A., Parlapani E., Bauer M., Heinsen H., Falkai P. Is brain banking of psychiatric cases valuable for neurobiological research?. Clinics (Sao Paulo) 2008, 63(2):255-266.
176. Schmitt A., Malchow B., Hasan A., Falkai P. The impact of environmental factors in severe psychiatric disorders. Front Neurosci 2014, 11(8):19.
177. Shahpasand K., Uemura I., Saito T., Asano T., Hata K., Shibata K., Toyoshima Y., Hasegawa M., Hisanaga S. Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease. J Neurosci 2012, 32(7):2430-2441.
178. Shelton R.C., Mainer D.H., Sulser F. CAMP-dependent protein kinase activity in major depression. Am J Psychiatry 1996, 153(8):1037-1042.
179. Shelton R.C., Manier D.H., Peterson C.S., Ellis T.C., Sulser F. Cyclic AMP-dependent protein kinase in subtypes of major depression and normal volunteers. Int J Neuropsychopharmacol 1999, 2(3):187-192.
180. Shelton R.C., Claiborne J., Sidoryk-Wegrzynowicz M., Reddy R., Aschner M., Lewis D.A., Mirnics K. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 2011, 16(7):751-762.
181. Shivakumar V., Kalmady S.V., Venkatasubramanian G., Ravi V., Gangadhar B.N. Do schizophrenia patients age early?. Asian J Psychiatry 2014, 10:3-9.
182. Singh V.K., Kalsan M., Kumar N., Saini A., Chandra R. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. Front Cell Dev Biol 2015, 3:2.
183. Smith E.N., Bloss C.S., Badner J.A., Barrett T., Belmonte P.L., Berrettini W., Byerley W., Coryell W., Craig D., Edenberg H.J., Eskin E., Foroud T., Gershon E., Greenwood T.A., Hipolito M., Koller D.L., Lawson W.B., Liu C., Lohoff F., McInnis M.G., McMahon F.J., Mirel D.B., Murray S.S., Nievergelt C., Nurnberger J., Nwulia E.A., Paschall J., Potash J.B., Rice J., Schulze T.G., Scheftner W., Panganiban C., Zaitlen N., Zandi P.P., Zöllner S., Schork N.J., Kelsoe J.R. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 2009, 14(8):755-763.
184. Soldner F., Laganière J., Cheng A.W., Hockemeyer D., Gao Q., Alagappan R., Khurana V., Golbe L.I., Myers R.H., Lindquist S., Zhang L., Guschin D., Fong L.K., Vu B.J., Meng X., Urnov F.D., Rebar E.J., Gregory P.D., Zhang H.S., Jaenisch R. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 2011, 146(2):318-331.
185. Song M., Mohamad O., Chen D., Yu S.P. Coordinated development of voltage-gated Na+ and K+ currents regulates functional maturation of forebrain neurons derived from human induced pluripotent stem cells. Stem Cells Dev 2013, 22(10):1551-1563.
186. Sprenger A., Küttner V., Biniossek M.L., Gretzmeier C., Boerries M., Mack C., Has C., Bruckner-Tuderman L., Dengjel J. Comparative quantitation of proteome alterations induced by aging or immortalization in primary human fibroblasts and keratinocytes for clinical applications. Mol BioSyst 2010, 6(9):1579-1582.
187. Sugden K., Pariante C.M., McGuffin P., Aitchison K.J., D'Souza U.M. Housekeeping gene expression is affected by antidepressant treatment in a mouse fibroblast cell line. J Psychopharmacol 2010, 24(8):1253-1259.
188. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131(5):861-872.
189. Tang S., Xie M., Cao N., Ding S. Patient-specific induced pluripotent stem cells for disease modeling and phenotypic drug discovery. J Med Chem 2015, [Epub ahead of print].
190. Tatullo M., Marrelli M., Falisi G., Rastelli C., Palmieri F., Gargari M., Zavan B., Paduano F., Benagiano V. Mechanical influence of tissue culture plates and extracellular matrix on mesenchymal stem cell behavior: a topical review. Int J Immunopathol Pharmacol 2015, pii: 0394632015617951.
191. Terwisscha van Scheltinga A.F., Bakker S.C., Kahn R.S., Kas M.J. Fibroblast growth factors in neurodevelopment and psychopathology. Neuroscientist 2013, 19(5):479-494.
192. Tigges J., Krutmann J., Fritsche E., Haendeler J., Schaal H., Fischer J.W., Kalfalah F., Reinke H., Reifenberger G., Stühler K., Ventura N., Gundermann S., Boukamp P., Boege F. The hallmarks of fibroblast ageing. Mech Ageing Dev 2014, 138:26-44.
193. Toll A., Mané A. Brain-derived neurotrophic factor levels in first episode of psychosis: A systematic review. World J Psychiatry 2015, 5(1):154-159.
194. Toouli C.D., Huschtscha L.I., Neumann A.A., Noble J.R., Colgin L.M., Hukku B., Reddel R.R. Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit. Oncogene 2002, 21(1):128-139.
195. Tosic M., Ott J., Barral S., Bovet P., Deppen P., Gheorghita F., Matthey M.L., Parnas J., Preisig M., Saraga M., Solida A., Timm S., Wang A.G., Werge T., Cuénod M., Do K.Q. Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet 2006, 79(3):586-592.
196. Tourjman V., Kouassi É., Koué M.È., Rocchetti M., Fortin-Fournier S., Fusar-Poli P., Potvin S. Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis. Schizophr Res 2013, 151(1-3):43-47.
197. Vangipuram M., Ting D., Kim S., Diaz R., Schüle B. Skin punch biopsy explant culture for derivation of primary human fibroblasts. J Vis Exp 2013, 77:e3779.
198. Waldera-Lupa D.M., Kalfalah F., Florea A.M., Sass S., Kruse F., Rieder V., Tigges J., Fritsche E., Krutmann J., Busch H., Boerries M., Meyer H.E., Boege F., Theis F., Reifenberger G., Stühler K. Proteome-wide analysis reveals an age-associated cellular phenotype of in situ aged human fibroblasts. Aging (Albany NY) 2014, 6(10):856-878.
199. Walker E., Mittal V., Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol 2008, 4:189-216.
200. Wang L., Lockstone H.E., Guest P.C., Levin Y., Palotás A., Pietsch S., Schwarz E., Rahmoune H., Harris L.W., Ma D., Bahn S. Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia. J Proteome Res 2010, 9(1):521-527.
201. Wassef A.A., O'Boyle M., Gardner R., Rose R.M., Brown A., Harris A., Nguyen H., Meyer W.J. Glucocorticoid receptor binding in three different cell types in major depressive disorder: lack of evidence of receptor binding defect. Prog Neuropsychopharmacol Biol Psychiatry 1992, 16(1):65-78.
202. Wolkowitz O.M., Epel E.S., Reus V.I., Mellon S.H. Depression gets old fast: do stress and depression accelerate cell aging?. Depress Anxiety 2010, 27(4):327-338.
203. Yagita K., Tamanini F., van Der Horst G.T., Okamura H. Molecular mechanisms of the biological clock in cultured fibroblasts. Science 2001, 292(5515):278-281.
204. Yang S., Van Dongen H.P., Wang K., Berrettini W., Bućan M. Assessment of circadian function in fibroblasts of patients with bipolar disorder. Mol Psychiatry 2009, 14(2):143-155.
205. Yao J.K., Leonard S., Reddy R. Altered glutathione redox state in schizophrenia. Dis Markers 2006, 22(1-2):83-93.
206. Yoo A.S., Sun A.X., Li L., Shcheglovitov A., Portmann T., Li Y., Lee-Messer C., Dolmetsch R.E., Tsien R.W., Crabtree G.R. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 2011, 476(7359):228-231.
207. Zeng H., Guo M., Martins-Taylor K., Wang X., Zhang Z., Park J.W., Zhan S., Kronenberg M.S., Lichtler A., Liu H.X., Chen F.P., Yue L., Li X.J., Xu R.H. Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells. PLoS One 2010, 5(7):e11853.
208. Zhan L., Kerr J.R., Lafuente M.J., Maclean A., Chibalina M.V., Liu B., Burke B., Bevan S., Nasir J. Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder. Neuropathol Appl Neurobiol 2011, 37(2):206-219.